Isoprostan - Versionsgeschichte

Penarc: Изопростаны

2016-10-31T02:51:38Z

Изопростаны

← Nächstältere Version		Version vom 31. Oktober 2016, 02:51 Uhr
Zeile 1:		Zeile 1:
	[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]		[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]
	Prostaglandine Stereoisomere während der Oxidation von Fettsäuren gebildet, hauptsächlich Arachidonsäure Cyclooxygenase Umgehung ~~[1]~~. Sie werden als Indikatoren für oxidativen Stress Ebene verwendet ~~[2]~~. Ausschuss für Nomenklatur der Eicosanoide genehmigt die einheitliche Nomenklatur der isoprostanes System ~~[3]~~.		Prostaglandine Stereoisomere während der Oxidation von Fettsäuren gebildet, hauptsächlich Arachidonsäure Cyclooxygenase Umgehung. Sie werden als Indikatoren für oxidativen Stress Ebene verwendet . Ausschuss für Nomenklatur der Eicosanoide genehmigt die einheitliche Nomenklatur der isoprostanes System.

	Die bekanntesten sind die F2-isoprostanes - eine Gruppe von 64 Molekülen, die Isomere von Prostaglandin F2 sind.<ref>[https://ru.wikipedia.org/w/index.php?title=%D0%98%D0%B7%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D0%BD%D1%8B&oldid=57734155 wikipedia(ru)]</ref>		Die bekanntesten sind die F2-isoprostanes - eine Gruppe von 64 Molekülen, die Isomere von [[Prostaglandin F2]] sind.<ref>[https://ru.wikipedia.org/w/index.php?title=%D0%98%D0%B7%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D0%BD%D1%8B&oldid=57734155 wikipedia(ru)Изопростаны]</ref>

Penarc am 31. Oktober 2016 um 02:49 Uhr

2016-10-31T02:49:52Z

← Nächstältere Version		Version vom 31. Oktober 2016, 02:49 Uhr
Zeile 1:		Zeile 1:
	[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]		[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]
			Prostaglandine Stereoisomere während der Oxidation von Fettsäuren gebildet, hauptsächlich Arachidonsäure Cyclooxygenase Umgehung [1]. Sie werden als Indikatoren für oxidativen Stress Ebene verwendet [2]. Ausschuss für Nomenklatur der Eicosanoide genehmigt die einheitliche Nomenklatur der isoprostanes System [3].

			Die bekanntesten sind die F2-isoprostanes - eine Gruppe von 64 Molekülen, die Isomere von Prostaglandin F2 sind.<ref>[https://ru.wikipedia.org/w/index.php?title=%D0%98%D0%B7%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D0%BD%D1%8B&oldid=57734155 wikipedia(ru)]</ref>


	{\| class="wikitable" \|		{\| class="wikitable" \|
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
Zeile 45:		Zeile 50:

	== Bibliographie ==		== Bibliographie ==

	<references />		<references />



	{{LinkWP_Miniartikel\|Txt=Isoprostan\|Link=?}}		{{LinkWP_Miniartikel\|Txt=Isoprostan\|Link=?}}

Penarc: sei Inkludist

2016-10-31T02:43:24Z

sei Inkludist

← Nächstältere Version		Version vom 31. Oktober 2016, 02:43 Uhr
Zeile 1:		Zeile 1:
	[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]		[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]
			{\| class="wikitable" \|
			\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
			\| align="left" width="800" \|<ref name="PMID15576482">Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref><ref name="PMID11350785">Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280(6):L1067-82 (2001) PMID 11350785 </ref><ref name="PMID18441279">Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol 39(4):383-9 (2008) PMID 18441279 </ref><ref name="PMID12471085">The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166(12 Pt 2):S25-30 (2002) PMID 12471085 </ref><ref name="PMID9409197">Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17(11):2309-15 (1997) PMID 9409197 </ref><ref name="PMID18948627">Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction. Circ Res 103(9):907-9 (2008) PMID 18948627 </ref><ref name="PMID12860842">The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. Heart 89(8):821-2 (2003) PMID 12860842 </ref>


			\|-
			\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Medline Suchterm/ Synonyme'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#00dfdf" \| '''Was ist das'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Struktur'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Physiologie'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Knockout'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Transgen'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Mutation'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Polymorphismus'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Genexpression'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Inhibitoren'''
			\| align="left" width="800"\|
			\|-
			\| bgcolor="#dfdfdf" \| '''Agonisten'''
			\| align="left" width="800"\|
			\|}


			== Bibliographie ==
			<references />



			{{LinkWP_Miniartikel\|Txt=Isoprostan\|Link=?}}

Kleiner: Der Seiteninhalt wurde durch einen anderen Text ersetzt: „Entstehender Artikel“

2016-10-30T22:25:55Z

Der Seiteninhalt wurde durch einen anderen Text ersetzt: „miniatur|Entstehender Artikel“

← Nächstältere Version		Version vom 30. Oktober 2016, 22:25 Uhr
Zeile 1:		Zeile 1:
	[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]		[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]
	~~{\| class="wikitable" \|~~
	~~\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''~~
	\| align="left" width="800" \|<ref name="PMID15576482">Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref><ref name="PMID11350785">Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280(6):L1067-82 (2001) PMID 11350785 </ref><ref name="PMID18441279">Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol 39(4):383-9 (2008) PMID 18441279 </ref><ref name="PMID12471085">The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166(12 Pt 2):S25-30 (2002) PMID 12471085 </ref><ref name="PMID9409197">Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17(11):2309-15 (1997) PMID 9409197 </ref><ref name="PMID18948627">Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction. Circ Res 103(9):907-9 (2008) PMID 18948627 </ref><ref name="PMID12860842">The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. Heart 89(8):821-2 (2003) PMID 12860842 </ref>


	\|-
	~~\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Medline Suchterm/ Synonyme'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#00dfdf" \| '''Was ist das'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Struktur'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Physiologie'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Knockout'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Transgen'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Mutation'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Polymorphismus'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Genexpression'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Inhibitoren'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Agonisten'''~~
	~~\| align="left" width="800"\|~~
	\|}


	~~== Bibliographie ==~~
	~~<references />~~



	~~{{LinkWP_Miniartikel\|Txt=Isoprostan\|Link=?}}~~

Ossip Groth am 17. April 2010 um 05:08 Uhr

2010-04-17T05:08:19Z

← Nächstältere Version		Version vom 17. April 2010, 05:08 Uhr
Zeile 2:		Zeile 2:
	{\| class="wikitable" \|		{\| class="wikitable" \|
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref name="PMID15576482">~~. et al.,~~ Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">~~. et al.,~~ New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref><ref name="PMID11350785">Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280(6):L1067-82 (2001) PMID 11350785 </ref><ref name="PMID18441279">Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol 39(4):383-9 (2008) PMID 18441279 </ref><ref name="PMID12471085">The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166(12 Pt 2):S25-30 (2002) PMID 12471085 </ref><ref name="PMID9409197">Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17(11):2309-15 (1997) PMID 9409197 </ref><ref name="PMID18948627">Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction. Circ Res 103(9):907-9 (2008) PMID 18948627 </ref><ref name="PMID12860842">The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. Heart 89(8):821-2 (2003) PMID 12860842 </ref>		\| align="left" width="800" \|<ref name="PMID15576482">Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref><ref name="PMID11350785">Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280(6):L1067-82 (2001) PMID 11350785 </ref><ref name="PMID18441279">Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol 39(4):383-9 (2008) PMID 18441279 </ref><ref name="PMID12471085">The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166(12 Pt 2):S25-30 (2002) PMID 12471085 </ref><ref name="PMID9409197">Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17(11):2309-15 (1997) PMID 9409197 </ref><ref name="PMID18948627">Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction. Circ Res 103(9):907-9 (2008) PMID 18948627 </ref><ref name="PMID12860842">The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. Heart 89(8):821-2 (2003) PMID 12860842 </ref>

Ossip Groth am 6. April 2010 um 18:24 Uhr

2010-04-06T18:24:08Z

← Nächstältere Version		Version vom 6. April 2010, 18:24 Uhr
Zeile 2:		Zeile 2:
	{\| class="wikitable" \|		{\| class="wikitable" \|
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref name="PMID15576482">. et al., Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">. et al., New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref>		\| align="left" width="800" \|<ref name="PMID15576482">. et al., Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">. et al., New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref><ref name="PMID11350785">Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280(6):L1067-82 (2001) PMID 11350785 </ref><ref name="PMID18441279">Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol 39(4):383-9 (2008) PMID 18441279 </ref><ref name="PMID12471085">The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166(12 Pt 2):S25-30 (2002) PMID 12471085 </ref><ref name="PMID9409197">Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17(11):2309-15 (1997) PMID 9409197 </ref><ref name="PMID18948627">Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction. Circ Res 103(9):907-9 (2008) PMID 18948627 </ref><ref name="PMID12860842">The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. Heart 89(8):821-2 (2003) PMID 12860842 </ref>


	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 47:		Zeile 49:


	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel\|Txt=Isoprostan\|Link=?}}

Ossip Groth am 9. Januar 2010 um 09:14 Uhr

2010-01-09T09:14:31Z

← Nächstältere Version		Version vom 9. Januar 2010, 09:14 Uhr
Zeile 2:		Zeile 2:
	{\| class="wikitable" \|		{\| class="wikitable" \|
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref name="PMID15576482">. et al., Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref>		\| align="left" width="800" \|<ref name="PMID15576482">. et al., Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">. et al., New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''

Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Freie Übersichtsartikel''' | align="left" width="800" |
2010-01-09T08:38:42Z

Die Seite wurde neu angelegt: „miniatur|Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Freie Übersichtsartikel''' | align="left" width="800" |<re...“

Neue Seite
[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]
{| class="wikitable" |
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| align="left" width="800" |<ref name="PMID15576482">. et al., Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref>
|-
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Medline Suchterm/ Synonyme'''
| align="left" width="800"|
|-
| bgcolor="#00dfdf" | '''Was ist das'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Struktur'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Physiologie'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Knockout'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Transgen'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Mutation'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Polymorphismus'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Genexpression'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Inhibitoren'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Agonisten'''
| align="left" width="800"|
|}

== Bibliographie ==
<references />

{{LinkWP_Miniartikel}}

← Nächstältere Version		Version vom 30. Oktober 2016, 22:25 Uhr
Zeile 1:		Zeile 1:
	[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]		[[Datei:pptpdtjpg1.png\|miniatur\|Entstehender Artikel]]
	~~{\| class="wikitable" \|~~
	~~\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''~~
	\| align="left" width="800" \|<ref name="PMID15576482">Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791-800 (2004) PMID 15576482 </ref><ref name="PMID10385607">New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J 13(10):1157-68 (1999) PMID 10385607 </ref><ref name="PMID11350785">Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280(6):L1067-82 (2001) PMID 11350785 </ref><ref name="PMID18441279">Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol 39(4):383-9 (2008) PMID 18441279 </ref><ref name="PMID12471085">The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166(12 Pt 2):S25-30 (2002) PMID 12471085 </ref><ref name="PMID9409197">Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17(11):2309-15 (1997) PMID 9409197 </ref><ref name="PMID18948627">Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction. Circ Res 103(9):907-9 (2008) PMID 18948627 </ref><ref name="PMID12860842">The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. Heart 89(8):821-2 (2003) PMID 12860842 </ref>


	\|-
	~~\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Medline Suchterm/ Synonyme'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#00dfdf" \| '''Was ist das'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Struktur'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Physiologie'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Knockout'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Transgen'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Mutation'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Polymorphismus'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Genexpression'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Inhibitoren'''~~
	~~\| align="left" width="800"\|~~
	\|-
	~~\| bgcolor="#dfdfdf" \| '''Agonisten'''~~
	~~\| align="left" width="800"\|~~
	\|}


	~~== Bibliographie ==~~
	~~<references />~~



	~~{{LinkWP_Miniartikel\|Txt=Isoprostan\|Link=?}}~~